Table 3.
Gender-wise prescription of SGLT2i
| SGLT2i prescribed | Gender | |
|---|---|---|
| Male (n=98) | Female (n=107) | |
| Empagliflozin (%) | 48 (49.0) | 56 (52.3) |
| Canagliflozin (%) | 31 (31.6) | 31 (29.0) |
| Dapagliflozin (%) | 19 (19.4) | 20 (18.7) |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.